Synthesis of 2— and 5—（1,1—Dimethy1—,2,5,6—tetrahydropyridinium—3—yl）oxadiazoline Iodides

A series of 2- and 5-(1,1-Dimethy1-,2,5,6-tetrahydropyridinium-3-yl)oxadiazoline Iodides,which might be used as M1 muscarinic receptor agonists,was synthesized from nicotinaldehyde and nicotinhydrazine,respectively.Their structures were characterized by ^1H NMR,IR,MS spectra and elemental analysis.     

3-（3-乙酰基-5-芳氧亚甲基-2,3-二氢-1,3,4-噁二唑-2-基）色酮类化合物的合成

3-（3-乙酰基-5-芳氧亚甲基-2;3-二氢-1;3;4-噁二唑-2-基）色酮类化合物的合成;噁二唑啉;色酮;合成     

2-芳基-3-N-丙酰基-5-(4-硝基苯基)-1,3,4-噁唑啉类化合物的合成与表征

4-硝基苯甲酰肼与芳醛反应得到相应的酰腙(2),2与丙酸酐脱水环化合成了标题化合物,其结构经1H NMR,IR,MS和元素分析表征。     

2-芳基-3-N-丙酰基，5-（4-硝基苯基）-1，3，4-噁唑啉类化合物的

4-硝基苯甲酰肼与芳醛反应得到相应的酰腙（2），2与丙酸酐脱水环化合成了标题化合物，其结构经^1H NMR，IR，MS和元素分析表征。     

2-芳基-3-N-丙酰基-5-(2-溴-4-氟苯基)-1，3，4噁二唑啉类衍生物的合成及抗菌活性

2-芳基-3-N-丙酰基-5-(2-溴-4-氟苯基)-1;3;4噁二唑啉类衍生物的合成及抗菌活性;噁二唑啉衍生物;合成;结构表征;抑菌活性     

1,1-二(苯并咪唑-2-基)-2-(喹喔啉-2-基)乙烯的合成及其性能

以邻苯二胺、丙二酸和果糖为主要原料,经Knoevenagel反应合成了一个新的芳稠杂环化合物——1,1-二(苯并咪唑-2-基)-2-(喹喔啉-2-基)乙烯(4),收率78.61%,其结构经1H NMR,IR和元素分析表征。利用UVVis和FL研究了4的光学性能,结果表明:4的最大吸收峰位于259 nm和383 nm;在320 nm激发波长激发下,4的λem位于495 nm,具有显著的日光紫外线吸收性能;TG/DTA分析表明:4的熔点为320℃,初始分解温度为402℃,具有良好的热稳定性。     

Synthesis of 2-and 6-chloro-3-(5-methyl-1,3,4-oxadiazol-2-yl)pyridines

A convenient synthesis of 2- and 6-chloro-3-(5-methyl-1,3,4-oxadiazol-2-yl)pyridines, 3 and 10 , utilizing the readily available amide 7 is described. Incorporation of the 3-t-butylamino-2-hydroxypropoxy side chain onto 3 provided 2 , a potential bioisostere of 1 . The antihypertensive activities of 2 and 12 were evaluated in the spontaneously hypertensive rat model.     

Synthesis of 3-(5-Aryl-1,3,4-oxadiazol-2-yl)chromones

A general method was proposed for the synthesis of 3-(5-aryl-1,3,4-oxadiazol-2-yl)chromones starting from 3-formylchromone. This aldehyde yields acylhydrazones, from which the corresponding unstable nitrile imines are generated. These intermediates undergo intramolecular 1,3-dipolar cycloaddition.     

4-(5-喹啉-3-基-四氮唑-2-基)丁胺的合成

三苯基膦钯催化3-溴喹啉完成氰化取代制得3-氰喹啉(1);1与叠氮化钠经[2+3]环加成合成了3-(2H-四氮唑-5-基)喹啉(2);2与N-(4-溴丁基)邻苯二甲酰亚胺反应制得2-[4-(5-喹啉-3-基-四氮唑-2-基)丁基]异吲哚-1,3-二酮(3);3经肼解合成了4-(5-喹啉-3-基-四氮唑-2-基)丁胺(4...     

3,3-二甲基-2-(3-甲基薁乙烯基)-3H-吲哚衍生物的合成

1-甲酰基薁-3-甲酸甲酯和2,3,3-三甲基-3H-吲哚衍生物发生缩合反应,合成了一系列3,3-二甲基-2-(3-甲基薁乙烯基)-3H-吲哚衍生物,收率48%～64%,其结构经~1H NMR,IR和元素分析表征.     

1-羟基-2-(1-甲基咪唑-2-基)乙烷-1,1-双膦酸的合成

自从Fleisch等入[1]发现双膦酸盐类化合物的亲骨作用以来,双膦酸盐化合物逐渐成为治疗骨骼方面疾病的药物,包括骨质疏松症,肿瘤病并发的高钙血症和骨痛,变形性骨炎(Paget’s病)和多发性骨髓瘤[2-3]。目前以唑来膦酸[化学名为2-(2-甲基-咪唑-1-基)-1-羟基乙烷-1,1-双膦酸]综合疗     

N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)酰胺类新化合物的合成及生物活性

以N-吡啶基吡唑甲酸和2-氨基-3-甲基苯甲酸为起始原料,经由亲核加成、环化和酰化等多步反应合成了一系列结构新颖的N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)酰胺类化合物.测试了所合成化合物的杀虫及抑菌活性,结果表明,新化合物大多化合物在200 mg·L^-1浓度下对东方粘虫(Mythimna separataWalker)具有一定的杀虫活性,尤其是N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)乙酰胺(8a)和N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-3-氯-2,2-二甲基丙酰胺(8e)致死率可达70%;部分化合物在50 mg·L^-1浓度下对油菜菌核病菌的抑菌活性相对较好(54.5%~63.6%),优于triadimefon和chlorantraniliprole;部分化合物如N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-3,3-二甲基丁酰胺80和N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-4-氟苯甲酰胺(8h)对苹果轮纹病菌具有中等抑菌活性.值得注意的是,化合物8e的杀粘虫活性和对油菜菌核病菌的抑菌活性都较为突出,可用作新农药创制研究的新型参考结构.     

3-N-乙酰基-2-芳基-5-苯基-1,3,4-噁唑啉类化合物的合成与表征

以自制的苯甲酰腙与乙酸酐环合,高收率地合成了3-N-乙酰基-2-芳基-5-苯基-1,3,4-噁唑啉类化合物。其结构经^1H NMR,IR,MS和元素分析表征,并对其质谱碎片裂解途径进行了探讨。     

3-三氟甲基联苯的合成

以3-三氟甲基苯胺为原料,叔丁醇亚硝酸酯为重氮化试剂,铜粉为催化剂,采用改良的Gomberg反应合成了3-三氟甲基联苯。最佳的反应条件为：3-三氟甲基苯胺20mmol,叔丁醇亚硝酸酯的用量为3-三氟甲基苯胺摩尔数的两倍,Cu的用量为3-三氟甲基苯胺摩尔数的0．6倍,于在40℃反应5h,其结构经^1H NMR,^13C NMR和IR表征。     

2-溴-3-(1H-吲哚-3)-N-甲基马来酰亚胺的合成

以琥珀酰亚胺为起始原料,经过溴化、甲基化后再与吲哚溴化镁加成反应合成了2-溴-3-(1H-吲哚-3)-N-甲基马来酰亚胺,总收率44.8%,其结构经1H NMR和IR确证.     

Synthesis and Crystal Structure of Methyl(7,7-Dimethyl-2-amino-4-(4-chlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-benzo-[b]-pyran-3-yl)Carboxylate

<正>The title compound methyl (7,7-dimemyl-2-amino-4-(4-chlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-benzo-[b]-pyran-3-yl) carboxylate (C19H20ClNO4, Mr = 361.81) was synthesized and crystallized. The crystal belongs to triclinic, space group P 1 with a = 8.519(2), b = 10.346(2), c = 11.481(3) A, α = 108.16(1), β = 107.78(2), γ= 91.83(2)°, Z = 2, V = 906.5(3) A3, Dc = 1.326 g/cm3, μ(MoKα) = 0.234 mm-1, F(000) = 380, R = 0.0467 and wR = 0.1270 for 3142 observed reflections (I > 2σ(I)). X-ray analysis reveals that the C(7), C(8), C(9), O(1), C(10) and C(11) atoms form a six-membered ring which adopts a boat conformation. In the ring, the distances of C(8)-C(9) and C(10)-C(11) are 1.332(3) and 1.357(3) A, respectively, which indicates that they are C=C double bonds. Another six-membered ring (C(8)-C(9)-C(15)-C(14)-C(13)-C(12)) adopts the half-chair confonnation. In addition, there are intermolecular hydrogen bonds in the crystal structure.     

Synthesis and Crystal Structure of 3,3-Dimethyl-7,11-di（thiophene- 2-yl）-2,4-dioxyspiro[5. 5]undecane- 1,5,9-trione

The title compound （C19H18O5S2） has been synthesized by the reaction of thio- phene-2-carboxaldehyde, isopropylidene malonate and 4-chloroaniline using [bmim]Br as solvent, and characterized by IR, ^1H NMR and X-ray single-crystal diffraction. The crystal belongs to monoclinic, space group P21/n with a = 9.4872（15）, b = 9.5148（13）, c = 20.634（3）A, β= 92.209（2）°, V= 1861.2（4）A^3, Mr= 390.45, Z = 4, Dc = 1.393 g/cm^3,μ（MoKα） = 0.313 mm^-1, F（000） = 816, the final R = 0.0685 and wR = 0.1685. X-ray analysis reveals that two six-membered rings adopt chair and planar conformations, respectively.     

Synthesis and Alkylation of 4-(2-Chlorophenyl)-3-cyano-6-hydroxy-5-(2-thienoyl)-6-trifluoromethylpiperidin-2-thione

4-(2-Chlorophenyl)-3-cyano-6-hydroxy-5-(2-thienoyl)-6-trifluoromethylpiperidin-2-thione, which was used for the synthesis of 2-allylthio-4-(2-chlorophenyl)-3-cyano-6-hydroxy-5-(2-thienoyl)-6-trifluoromethyl-1,4,5,6-tetrahydropyridine, was obtained by the reaction of 2-thienoyltrifluoroacetone with 2-chlorophenylphenylmethylenecyanothioacetamide or with a mixture of 2-chlorobenzaldehyde and cyanothioacetamide in the presence of N-methylmorpholine. The molecular and crystal structure of the piperidinthione have been established by X-ray crystallography.